For its next product launch, menopause solutions company Alloy is targeting the body. Launching Tuesday and following on the ...

Many women are currently facing struggles with getting access to proper menopause treatment so endocrinologist Dr. Rekha ...

More women are using hormone replacement therapy to help with menopausal symptoms like hot flashes. That has led to ...

Don't blame a menopause fad. There is little incentive for pharmacy companies to ensure smooth, consistent access.

Alexis Dunne always plans how to best treat her patients’ perimenopause and menopause symptoms. The Chicago-area physician wants to ensure that the hormone replacement therapy she prescribes helps ...

DMPA denotes depot medroxyprogesterone acetate, GAHT gender-affirming hormone therapy, GnRH gonadotropin-releasing hormone, HRT hormone-replacement therapy, and MPA medroxyprogesterone acetate.

Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 Shutterstock Demand for estrogen patches surged 26% after the FDA removed a black box ...

A surge in demand since last year for estrogen patches to ease menopause symptoms has strained supplies and led to shortages, sparking a scramble for medicines that industry sources say could last up ...

More women are seeking treatment for menopause and perimenopause, driving a shortage of estrogen patches, one of the most commonly used forms of hormone therapy. Manufacturers are struggling to keep ...

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Last summer, Angela Motter started experiencing some changes that began to interfere ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...